• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » psychotherapy

Articles Tagged with ''psychotherapy''

Beyond Medications: Psychosocial Methods for Helping Challenging Kids

September 1, 2015
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
George H. Stewart, MD
Foster children tend to be over-medicated. Surveys show that foster youth receive 5 times the number of psychotropic medications, frequently three or four simultaneously, as privately insured children. What else, beside medications, can we offer foster children who are often struggling with psychiatric issues and difficult and unfamiliar family environments?
Read More

The Diagnosis and Treatment of Hoarding Disorder [Free Article]

July 13, 2015
Jessica E. Zoltani, MD
...
Read More

The Vast Landscape of Services that is “Rehab”

July 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Susan Hochstedler, RN, LADC
If a patient comes in and says, “doc, I think I need to go to rehab,” what should you do? Most people think of rehabs as residential facilities, but these days, the term “rehab” includes a broad spectrum of treatment settings, most of which, in fact, are not residential—only 10% of people receiving specialized addiction services go to residential rehab.
Read More

Book Review: Inside Rehab—What Really Goes On in Rehab Facilities?

July 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Daniel Carlat, MD
What goes on inside a residential rehab program? Inquiring minds would love to know, especially those of us who are treating addicts and counseling concerned family members. Rehab has traditionally been a kind of black box, an opaque entity where addicts enter, and 30 days later exit with an epiphany and a lifelong commitment to sobriety. Until they relapse and go back to another rehab, that is.
Read More

The Case Against Residential Rehab

July 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
There is a wide array of treatment options for patients with various levels of addiction issues, but of those rehab is one of the most well-known. Dr. Willenbring makes the argument that inpatient rehab is not an effective method to combat addiction.
Read More

The Substance Abuse Interventionist

July 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
An intervention has become the starting place for an addict's journey to rehab. We all have a notion of family and friends gathering around a patient and sharing their feelinings. Mr. Gallant is a professional interventionist, who has planned and executed interventions for 28 years. This interview shares his expertise in the area and provides his sense of how interventions fit into the addiction treatment process.
Read More

How to Treat Tobacco Use Disorder—A Primer

June 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Daniel Carlat, MD
You may or may not consider smoking cessation to be part of your job description. But tobacco use disorder is a psychiatric syndrome, per DSM-5.
Read More

Binge Eating Disorder: Should You Use Vyvanse?

June 1, 2015
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Talia Puzantian, PharmD, BCPP Clinical psychopharmacology consultant in private practice, Los Angeles, CA. www.taliapuzantian.com Dr. Puzantian has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.   Daniel Carlat, MD
Editor-in-Chief, Publisher, The Carlat Report.
Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
In January of this year, the FDA approved the stimulant lisdexamfetamine (Vyvanse) as the first drug with an indication for binge eating disorder (BED). Patients are hearing the buzz and may be asking you to prescribe it, but you may have some questions first.
Read More

Understanding the New World of E-Cigarettes

June 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Dr. Eissenberg discusses e-cigarettes, including an overview of the product, ways they are used and misused, and how they fit into the landscape of smoking cessation methods.
Read More

It Pays to Quit Smoking

June 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Quitting smoking requires a lot of motivation—something our patients don’t always have. Since money is a great motivator, various programs that pay patients to quit have been tried over the years. But how well does this technique work?
Read More
Previous 1 2 … 9 10 11 12 13 14 15 16 17 … 22 23 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2639254965.jpg
    General Psychiatry

    Psychopharm Secrets: Starting Meds

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.